In world first, scientists use CRISPR to fix baby's unique genetic mutation

The results, published on Thursday, are a landmark in the 50-year quest to read and repair the code of life.

May 15, 2025 Check out STAT+

Sponsored By

To our New York City area readers: Join us at our next STAT Locals event on June 5 to connect with others in the life sciences community (and get food and drink on us!).

Children's Hospital of Philadelphia CRISPR is used in landmark treatment to correct genetic misspelling of a single patient In a world first, scientists used CRISPR to fix a baby's unique genetic mutation. The report offers hope for personalized treatments of rare diseases. By Jason Mast Opinion: I was a Theranos whistleblower. Here's what I think Elizabeth Holmes is up to STAT First Opinion essay: Tyler Shultz says he always knew Elizabeth Holmes would have a second act, "shocked it's starting while she's still behind bars." By Tyler Shultz STAT+ | FDA commissioner says new vaccine 'framework' for industry is coming within weeks A top agency official is meeting with industry and FDA staff as he works on guidance clarifying the FDA's expectations for vaccines. By Lizzy Lawrence Sarah Gonzales for STAT 'What wouldn't I be worried about?': Research leaders discuss threats to U.S. science Scientists decried grant terminations and fear in academia as U.S. research faces mounting pressure, loss of global credibility By Anil Oza STAT+ | What to know about Summit Therapeutics' looming clinical trial readout In this week's edition of "Adam's Biotech Scorecard," Adam offers a preview of what may be the most important study readout coming this summer. By Adam Feuerstein STAT+ | As AI in health care proliferates, so do legal questions concerning its use Experts at STAT Breakthrough Summit West said developer disclaimers can be disingenuous, and keeping "a human in the loop" doesn't improve matters. By Tara Bannow Adobe Opinion: Ensuring most-favored nation drug pricing doesn't sicken us If the U.S. rationalizes how it pays for medicines, consumers, employers, and government payers would see fair prices. By Darius Lakdawalla and Dana P. Goldman Trump's drug-pricing plan and a potential Theranos 2.0 STAT reporters chat about Trump's drug-pricing plan, RFK Jr.'s congressional hearings, and a new blood-testing company. By Elaine Chen and Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser